Price$35.17-5.06 (-12.58%)
2026-01-212026-04-24
News · 26 weeks21-75%
2025-11-022026-04-26
Mix890d
- Other3(38%)
- SEC Filings3(38%)
- Insider1(13%)
- Leadership1(13%)
Latest news
25 items- PRKewaunee Scientific Corporation Appoints Jorge Santos as Vice President of International Sales, Laboratory Products GroupSTATESVILLE, N.C., April 14, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced the appointment of Jorge Santos as VP – International Sales – Lab Products Group, further strengthening the Company's commercial leadership as it accelerates growth in key global markets. Santos joins Kewaunee as the newest member of the Company's leadership team and will report directly to President and Chief Executive Officer, Thomas D. Hull III. "Jorge's appointment marks a significant step forward in Kewaunee's growth strategy outside of the North American market,"
- INSIDERSEC Form 4 filed by Pyle Margaret B4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- SECSEC Form 10-Q filed by Kewaunee Scientific Corporation10-Q - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
- SECKewaunee Scientific Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
- PRKewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2026STATESVILLE, N.C., March 11, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced results for its third quarter ended January 31, 2026. Fiscal Year 2026 Third Quarter Results:Sales during the third quarter of fiscal year 2026 were $69,399,000, an increase of 3.3% compared to sales of $67,167,000 from the prior year's third quarter. Pre-tax earnings for the quarter were $1,604,000 compared to $1,275,000 for the prior year quarter, an increase of 25.8%. Net earnings were $692,000 compared to net earnings of $1,354,000 for the prior year quarter. EBITD
- PRKewaunee Scientific and Nu Aire Inc. to Attend analytica 2026 in MunichSTATESVILLE, N.C., March 3, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced that the Company will attend the 2026 analytica tradeshow and conference, taking place in Munich from March 24-27. Kewaunee will be joined by the Company's recently acquired subsidiary, Nu Aire, Inc. (NuAire), a proven leader in containment and biosafety technologies. Together, they will showcase a complete and complementary portfolio of laboratory infrastructure and safety-focused solutions designed to support the needs of modern lab environments worldwide.Established
- SECKewaunee Scientific Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
- PRKewaunee Scientific to Report Results for Third Quarter Fiscal Year 2026STATESVILLE, N.C., Feb. 25, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced that the Company plans to release its third quarter fiscal year 2026 financial results on Wednesday, March 11, 2026 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the release. About Kewaunee Scientific Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's products
- INSIDERPresident, CEO Hull Thomas David Iii sold $81,638 worth of shares (2,177 units at $37.50), decreasing direct ownership by 6% to 33,000 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERChief Financial Officer Gardner Donald T. Iii sold $75,140 worth of shares (2,000 units at $37.57), decreasing direct ownership by 17% to 9,564 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERPresident, CEO Hull Thomas David Iii sold $24,790 worth of shares (658 units at $37.67), decreasing direct ownership by 2% to 35,177 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERPresident, CEO Hull Thomas David Iii sold $33,601 worth of shares (884 units at $38.01), decreasing direct ownership by 2% to 35,835 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERPresident, CEO Hull Thomas David Iii sold $39,000 worth of shares (1,000 units at $39.00), decreasing direct ownership by 3% to 36,719 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERPresident, CEO Hull Thomas David Iii sold $39,000 worth of shares (1,000 units at $39.00), decreasing direct ownership by 3% to 37,719 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- SECSEC Form 10-Q filed by Kewaunee Scientific Corporation10-Q - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
- SECKewaunee Scientific Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
- PRKewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2026STATESVILLE, N.C., Dec. 10, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced results for its second quarter ended October 31, 2025. Fiscal Year 2026 Second Quarter Results: Sales during the second quarter of fiscal year 2026 were $70,096,000, an increase of 46.8% compared to sales of $47,764,000 from the prior year's second quarter. Pre-tax earnings for the quarter were $3,453,000 compared to $3,931,000 for the prior year quarter, a decrease of 12.2%. Net earnings were $2,445,000 compared to net earnings of $3,008,000 for the prior year quarte
- SECKewaunee Scientific Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
- PRKewaunee Scientific Announces Successful Debt Refinancing and Full Repayment of Seller Notes From the Company's Acquisition of Nu Aire, Inc.STATESVILLE, N.C., Dec. 4, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU), a recognized leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products, today announced its successful debt refinancing and the full repayment of its Seller Notes. On December 4, 2025, Kewaunee Scientific Corporation (the "Company" or "Kewaunee") successfully repaid in full and ahead of schedule its Seller Notes, entered into November 1, 2024, in connection with the Company's acquisition of Nu Aire, Inc. ("Nu Aire"). The Seller No
- SECKewaunee Scientific Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Filer)
- PRKewaunee Scientific to Report Results for Second Quarter Fiscal Year 2026STATESVILLE, N.C., Nov. 26, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ:KEQU) today announced that the Company plans to release its second quarter fiscal year 2026 financial results on Wednesday, December 10, 2025 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the release. About Kewaunee Scientific Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's pr
- INSIDERChief Financial Officer Gardner Donald T. Iii sold $128,280 worth of shares (3,000 units at $42.76), decreasing direct ownership by 21% to 11,564 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- SECSEC Form 144 filed by Kewaunee Scientific Corporation144 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Subject)
- INSIDERVP - Human Resources Phillips Elizabeth D sold $297,219 worth of shares (6,880 units at $43.20), decreasing direct ownership by 45% to 8,248 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
- INSIDERPresident, CEO Hull Thomas David Iii sold $43,090 worth of shares (1,000 units at $43.09), decreasing direct ownership by 3% to 38,719 units (SEC Form 4)4 - KEWAUNEE SCIENTIFIC CORP /DE/ (0000055529) (Issuer)
KEQU FAQ
5 questionsWhat does Kewaunee Scientific Corporation do?
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. It operates in two segments, Domestic and International. The company's products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. Its laboratory products are used in chemistry, physics, biology, and other general science laboratories in the...Where does KEQU stock trade?
Kewaunee Scientific Corporation (KEQU) is listed on NASDAQ.What sector and industry is KEQU in?
Kewaunee Scientific Corporation operates in the Industrials sector, Medical Specialities industry.What companies are similar to KEQU?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), NTRA (Natera Inc.). Compare KEQU side-by-side with any of them on Quantisnow.How can I track KEQU on Quantisnow?
Quantisnow aggregates Kewaunee Scientific Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow KEQU to receive live email and push alerts on every new disclosure.